The goals of this study are to determine whether 10 candidate genes influence susceptibility to SLE and to 2 specific disease manifestations; lupus nephritis and the antiphospholipid antibody (APLA) syndrome. The GCRC will be utilized to obtain blood samples for APLA testing, as well as serum and DNA samples for long-term storage (and future use). In addition, during the GCRC visit SLE patients and family members will complete the enrollment process including provision of buccal smear samples and questionnaire information.
Showing the most recent 10 out of 634 publications